Uncovering the Predisposing Factors of Mucormycosis: Insights from Systematic Review

被引:0
作者
Ravindhiran, Ramya [1 ]
Chidambaram, Kumarappan [2 ]
Subramanian, Anandalakshmi [3 ]
Velayutham, Suresh [4 ]
Ramar, Mohankumar [5 ]
Dhandapani, Kavitha [1 ]
机构
[1] Avinashilingam Inst Home Sci & Higher Educ Women, Dept Biochem Biotechnol & Bioinformat, Coimbatore 641043, Tamil Nadu, India
[2] King Khalid Univ, Coll Pharm, Dept Pharmacol, Abha 61421, Saudi Arabia
[3] King Khalid Univ, Coll Med, Dept Microbiol & Clin Parasitol, Abha 61421, Saudi Arabia
[4] TN MGR Med Univ, JKKMMRF Annai JKK Sampoorani Ammal Coll Pharm, Namakkal 638183, Tamil Nadu, India
[5] UNIV CONNECTICUT, SCH PHARM,PHARMACOL & TOXICOL SECT, STORRS, CT 06268 USA
关键词
Etiology; COVID-19; Diabetes mellitus; Epidemiology; Fungal infection mucorales; Mucormycosis; SERIOUS FUNGAL-INFECTIONS; UNITED-STATES; BURDEN; DISEASES; EPIDEMIOLOGY; ZYGOMYCOSIS; PREVALENCE; TAXONOMY; PATIENT;
D O I
10.1007/s12088-025-01491-y
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Mucormycosis is a life-threatening fungal infection with high morbidity and mortality, particularly affecting immunocompromised individuals. Despite its growing clinical significance, its true global prevalence remains unclear. This systematic review identifies the key risk factors, epidemiological trends, and clinical challenges associated with mucormycosis. A comprehensive literature search was conducted to analyze global case reports, underlying predisposing conditions, and regional variations in disease manifestation. The leading risk factor in developed nations is hematological malignancies, while uncontrolled diabetes mellitus dominates in regions like India. Environmental and climatic factors influence fungal exposure and disease progression. Diagnosis remains challenging due to nonspecific symptoms, contributing to delayed treatment and poor outcomes. Early recognition of risk factors and improved diagnostic strategies are critical to reducing mucormycosis-related mortality. Public health initiatives must prioritise awareness, especially in high-risk populations. Further research is needed to address gaps in treatment and prevention.
引用
收藏
页数:14
相关论文
共 116 条
[1]  
Afroze SN, 2017, CONTEMP CLIN DENT, V8, P662, DOI 10.4103/ccd.ccd_558_17
[2]   Mucormycosis in the Eastern Mediterranean: a seasonal disease [J].
Al-Ajam, MR ;
Bizri, AR ;
Mokhbat, J ;
Weedon, J ;
Lutwick, L .
EPIDEMIOLOGY AND INFECTION, 2006, 134 (02) :341-346
[3]   Population-Based Survey of Filamentous Fungi and Antifungal Resistance in Spain (FILPOP Study) [J].
Alastruey-Izquierdo, A. ;
Mellado, E. ;
Pelaez, T. ;
Peman, J. ;
Zapico, S. ;
Alvarez, M. ;
Rodriguez-Tudela, J. L. ;
Cuenca-Estrella, M. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (07) :3380-3387
[4]  
Alekseyev Kirill, 2021, J Med Cases, V12, P85, DOI 10.14740/jmc3637
[5]   Mucormycosis in 2023: an update on pathogenesis and management [J].
Alqarihi, Abdullah ;
Kontoyiannis, Dimitrios P. ;
Ibrahim, Ashraf S. .
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
[6]  
[Anonymous], About us
[7]  
[Anonymous], Aspergillus & Aspergillosis Website The Burden of Serious Fungal Diseases in Japan
[8]  
[Anonymous], About us
[9]   Mucormycosis associated with COVID-19 in two kidney transplant patients [J].
Arana, Carolt ;
Cuevas Ramirez, Rafael E. ;
Xipell, Marc ;
Casals, Joaquim ;
Moreno, Asuncion ;
Herrera, Sabina ;
Bodro, Marta ;
Cofan, Frederic ;
Diekmann, Fritz ;
Esforzado, Nuria .
TRANSPLANT INFECTIOUS DISEASE, 2021, 23 (04)
[10]   COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment [J].
Arastehfar, Amir ;
Carvalho, Agostinho ;
van de Veerdonk, Frank L. ;
Jenks, Jeffrey D. ;
Koehler, Philipp ;
Krause, Robert ;
Cornely, Oliver A. ;
Perlin, David S. ;
Lass-Floerl, Cornelia ;
Hoenigl, Martin .
JOURNAL OF FUNGI, 2020, 6 (02) :1-17